Booth No.6B-35
CategoryOutsourcing
SELVITA S.A.
Booth No.：6B-35
Category：Outsourcing
Company Information
Email：
gabriela.ujek@selvita.com
TEL： +48-539-190-791
Address： 30-394
Podole 79, Krakow POLAND URL： http://selvita.com
Podole 79, Krakow POLAND URL： http://selvita.com
Contact in Japan
Japan agent： Selvita
Email：
nobuhisa.asano@selvita.com
TEL： +81-90-2157-5182
Address： 2-24-5-212, Sakura-Shinmachi,Setagaya-ku, Tokyo
Selvita is a preclinical Contract Research Organization providing multidisciplinary support in resolving the unique challenges of research within the areas of drug discovery and drug development studies.
Selvita was established in 2007 and currently employs almost 900 professionals, of which over 40% hold a PhD degree. The Company research sites are located in Krakow (HQ) and Poznan, Poland, as well as Zagreb, Croatia. Selvita’s international offices are located in Cambridge, MA, and San Francisco Bay Area, in the U.S., as well as in Cambridge, the UK.
Selvita was established in 2007 and currently employs almost 900 professionals, of which over 40% hold a PhD degree. The Company research sites are located in Krakow (HQ) and Poznan, Poland, as well as Zagreb, Croatia. Selvita’s international offices are located in Cambridge, MA, and San Francisco Bay Area, in the U.S., as well as in Cambridge, the UK.
Company information
| Address | 30-394 Podole 79, Krakow POLAND |
|---|---|
| TEL | +48-539-190-791 |
| URL | http://selvita.com |
| gabriela.ujek@selvita.com |
| Product Classification |
Integrated Drug Discovery (Hit ID, Hit-to-Lead and Lead Optimization) on small molecules, PROTACs and peptides Medicinal Chemistry and compound design Synthetic route scouting and process chemistry Computational chemistry and AI-assisted Drug Discovery Full panel of high throughput assays for ADME/DMPK profiling Development of custom in vitro assays for supporting HTS Structural Biology and custom Recombinant protein production In vivo rodent models related to oncology, fibrosis, inflammation, autoimmune diseases and infectious diseases Non-GLP tox studies Translational studies using patient-derived material CMC analytical support for Biologics and small molecules Bioanalytical support for small molecules and proteins Formulation development for Biologics Method developed, validation and transfer Quality Control tests for the EU market ICH stability studies ICH Q6B protein characterization |
|---|
Contact in Japan
| Japan Agent | Selvita |
|---|---|
| Address | 2-24-5-212, Sakura-Shinmachi,Setagaya-ku, Tokyo |
| TEL | +81-90-2157-5182 |
| nobuhisa.asano@selvita.com |